|
61
|
Pharm/tox |
基因治療製劑非臨床藥毒理研發策略指導原則
|
2025-09-24 |
|
62
|
Product specific BE guideline |
Clopidogrel Bisulfate Tablets_生體相等性試驗指導原則
|
2025-09-24 |
|
63
|
Product specific BE guideline |
Dapoxetine FCT_生體相等性試驗指導原則
|
2025-09-24 |
|
64
|
Product specific BE guideline |
Erlotinib_生體相等性試驗指導原則
|
2025-09-24 |
|
65
|
Product specific BE guideline |
Memantine HCl tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
66
|
Product specific BE guideline |
Paliperidone ER Tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
67
|
Product specific BE guideline |
Pregabalin capsule_生體相等性試驗指導原則
|
2025-09-24 |
|
68
|
Product specific BE guideline |
Solifenacin succinate tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
69
|
Product specific BE guideline |
Zolpidem Tartrate ER Tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
70
|
Product specific BE guideline |
Zolpidem Tartrate Tablet_生體相等性試驗指導原則
|
2025-09-24 |
